From: "Gina Miller" Subject: (associates) HP labs at forefront of nanotechnology article Date: 03 Sep 1999 15:43:42 -0700 See this nano/url "Brilliant New World" article http://www.hp.com/ghp/features/nano/index.html Gina "Nanogirl" Miller Nanotechnology Industries Web: http://www.nanoindustries.com Personal website: http://www.homestead.com/nanotechind/nothingatall.html Get the Nanotechnology Industries newsletter at: http://www.homestead.com/nanonews/describe.html E-mail: nanogirl@halcyon.com "Nanotechnology: solutions for the future." - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: "Gina Miller" Subject: (associates) Weekend Nanogirl News~ Date: 05 Sep 1999 21:38:18 -0700 Weekend Nanogirl news~Tidbits to tide you over *To see more concerning Hewlett Packards Stan Williams and his research involving nanometer-scale structures for computing and communications: pi= ck up the Sept-Oct issue of "MIT's Magazine of Innovation TECHNOLOGY Review.= " There is a 4 page articles called "Computing after Silicon" with an interview on Williams theories on nanometer-scaled components cheaply and easily assembled using simple chemistry. You can aquire the issue at your local newstand/bookstore or go to MIT's web site. *Image of Electron Orbitals Confirms Controversial Bonding Hypothesis. Us= ing a combination of convergent beam electron diffraction and X-ray diffracti= on techniques, a team of materials researchers at Arizona State University h= ave achieved startlingly clear images of electron orbitals responsible for bonding in Cu2O, also known as cuprite, a ceramic semiconductor with a ra= re structure. http://clasdean.la.asu.edu/news/cuprite.htm *Virginia Tech Researchers Create New Family Of Molecule, Solve Fullerene Processing Mystery BLACKSBURG, Aug. 30, 1999 -- Leaky lab equipment and Virginia Tech researchers' eagle eyes have resulted in a new family of molecules with potential applications ranging from medicine to optical-electronic device= s, and beyond. The researchers report in the Sept. 2, 1999, issue of Nature that they can produce C80 fullerenes containing three metal atoms ("Small-bandgap endohedral metallofullerenes in high yield and purity"). http://fbox.vt.edu:10021/ur/news/Archives/Aug99/99348.html * Wistar Institute Scientists Find Key Piece In Gene Regulation Puzzle Philadelphia -- For the first time, scientists working in The Wistar Institute laboratory of Ronen Marmorstein, PhD, in collaboration with Shelley Berger, PhD, have determined the three-dimensional structure of a key enzyme involved in gene activation. http://www.wistar.upenn.edu/internet/new_site/pr_pages/pr_9.99_2.html *Order Chemical Reviews special thematic issue:Nanostructures July 1999. http://pubs.acs.org/journals/chreay/thematic/99/nanostructure.html *For decades, pharmaceutical companies have struggled to overcome the molecular equivalent of the Great Wall of China: the outer membrane of cells, which prevents all but the tiniest of proteins from entering. Now researchers have slipped a protein that's more than 200 times larger than the average drug into the cells of living mice and shown that the protein functions. http://medicine.wustl.edu/~wumpa/news/dowdyprotein.html *Scientists at Jefferson Medical College have found a way to isolate hard-to-find hematopoietic stem cells. The researchers, in identifying a chemical beacon =96 a protein marker =96 on the cell, believe the new wor= k will lead to laboratory production of all types of blood cells for transfusion= s and innovative approaches for bone marrow transplants and gene therapy. http://www.jeffersonhealth.org/news/1999/083199.html *Loss of Molecular Handbrakes Compromises Immune System. Two related proteins that act as brakes for a variety of cellular growth processes appear to play a critical role in ensuring that both blood cells and immu= ne system cells are neither overactive nor overabundant. One of the proteins may play a role in the development of certain types of leukemia. http://www.hhmi.org/news/ihle.htm *OSU Medical Center uses robotic heart surgery technique A new minimally invasive heart surgery technique utilizing robotic technology has been performed at The Ohio State University Medical Center. It was the first use in North America of the da Vinci Computer-Enhanced Surgical System which uses sensitive remote-controlled surgical instrumen= ts guided by a surgeon at a computer keyboard. http://www.acs.ohio-state.edu/units/research/archive/1stsurg.htm *Cloning gives second chance for bull. A calf has been cloned from a 21-year-old celebrity bull, the oldest animal yet reproduced using this technology. http://news.bbc.co.uk/hi/english/sci/tech/newsid_437000/437391.stm *Genetic finds get smarter, faster Sydney Morning Herald) Gene breakthroughs that could lead to ways to boost intelligence, extend = our life span, and cure diabetes were among many genetic findings announced i= n international journals this week. http://www.smh.com.au/news/9909/04/text/national13.html *New Scientist book review of: The Making of Intelligence by Ken Richards= on, Weidenfeld & Nicolson. http://www.newscientist.com/ns/19990904/whatmakesu.html *DNA traces humble origins of noble wines.A grape variety once banned as inferior and unworthy is actually the ancestor of some of France=92s most highly prized wines, says a researcher who analyzed the genetic history o= f grapes from such legendary wine centers as Champagne and Burgundy. http://www.msnbc.com/news/307475.asp *A man with muscular dystrophy has been injected with genes for a needed muscle protein, a method which may find success in treating the disease. http://abcnews.go.com/sections/living/DailyNews/md_genetherapy990903.html *God Welcome in Biologist's Lab Religion and science aren't mutually exclusive in Francisco J. Ayala's universe. He's an evolutionary biologist and an ordained priest. Ayala believes in God even as he stands stooped over in his laboratory, jugglin= g beakers and breeding new kinds of fruit flies. http://www.latimes.com/excite/990904/t000079131.html *Everyone's guide to DNA Computers. http://dna2z.com/dnacpu/dne.html *Read the letter that the American Society for Cell Biology wrote to the Governor of Kansas in response to the recent ruling by that state's Board= of Education regarding the teaching of evolution. http://www.faseb.org/ascb/ *Future riches may lie in genes Companies with potential to revolutionise health care set to be stockmarket stars. WHEN the first biotechnology companies went public in the 1980s, US stockbrokers likened the investmen= t opportunity to buying [ Xerox ] or IBM at its initial public offering. So when the genomics firms tapped the public markets a decade later, it was = no surprise that the analogy that brokers made was to [ Microsoft ] . There = may be more than a germ of truth to this genomics pitch. If you believe that some companies have the potential to create a new industry, or to alter t= he rules for an existing one, then those are stocks to own for the long term. The thesis behind the genomics companies is that deciphering all the gene= s that make up the human genome, or the sum of the body's genetic informati= on, will prompt huge changes in health care. In this vision, gene-based diagnostic tests will predict disease years or decades before it occurs, = and drugs of extraordinary specificity will prevent or cure illnesses such as cancer, heart disease and stroke - without side effects. The leading drug companies have already paid hundreds of millions of dollars to the genomi= cs firms to gain access to their data, and the betting is that the health-ca= re system will one day pay billions for genomics-based drugs. The shares may= be volatile, and investors may want to use big movements as trading opportunities, but basically, those who believe the thesis may want to ow= n them almost regardless of how expensive they become. And those who do not believe it, of course, may want to stay away. Shares of two of the bigges= t gene merchants have been on a tear as investors have reacted to several gene-related discoveries announced by Maryland-based [ Human Genome Sciences ] . Shares in Human Genome, the early player and the only one to take its own drugs into clinical trial, are up more than 80 per cent sinc= e January 1. They closed on Wednesday at US$71.375 more than three times th= eir 52-week low of $22.75 last September. The stock of [ Millennium Pharmaceuticals ] , based in Massachusetts, has tended to follow that of Human Genome, even though Millennium has yet to develop drugs of its own. But it has reaped more than $1 billion from corporate partnerships and pl= ans to acquire a drug later this year. At its closing price of $62.50 on Wednesday it has more than doubled since January 1 and is up sixfold from its low last September. The other two big genomics stocks are in companie= s that sell genetic data-bases to big drug companies. In comparison to those in the first category, their shares seem like valu= e stocks. Celera Genomics Group Maryland was spun off from [ PE Corp ] at $21.31 a share in May. It closed on Wednesday at $30.625. Shares of Incyt= e Pharmaceuticals of California closed at $28.25 on Wednesday down more tha= n 20 per cent since January, largely because of the perception that an independent Celera poses a threat to its core business. Michael Murphy, editor of the California Technology Stock Letter, recommends a basket of Human Genome, Incyte and Celera. "Own all three, because what you want to= do here is get a position in what will clearly be the basis of medicine in t= he 21st century," he said. He thinks Human Genome could hit $150 by 2002 but has not established targets for the others. Mr Murphy excludes Millennium because it has diversified into agriculture and diagnostic sectors, and h= e no longer sees it as a pure genomics play. But that assessment is not universal. Viren Mehta, an analyst with Mehta Partners, a health-care sto= ck research firm, thinks Millennium has the best business model for both finding partners and prospering on its own. "What is important to remembe= r is that up to now, the majority of drug discovery successes of smaller companies had to be shared with larger companies," he said. "It is quite likely the future will be no different." Most big-selling dr= ugs are pills, which must be based on small molecules produced through medici= nal chemistry, province of the big drug firms. "Millennium has chosen to first establish a robust scientific infrastructure, and from there to create very lucrative partnerships, whe= re a substantial portion of the combined success will still become the exclusive property of Millennium," Mr Mehta said. "If you are going to bu= y one stock and put it away for your grandchildren, which will it be? We ha= ve recommended Millennium for a long time." But other analysts say Millennium's future remains dependent on the succe= ss of its partners or the acquisition of a compound that may become a successful drug, for which it will have to compete with the same deep-pocketed companies it partners with. Human Genome Sciences is alone among the genomics companies in having created drugs - three of them, all undergoing clinical trials. "We tend to favour companies that not only supply genes or data bases to corporate partners but, most importantly, c= an develop their own drugs," said Anthony Butler, an analyst with [ Lehman Brothers ] , which took Human Genome public in 1992. "It's amazing what j= ust one drug will do for your value," Mr Butler said. The New York Times (Copyright 1999) Gina "Nanogirl" Miller Nanotechnology Industries Web: http://www.nanoindustries.com E-mail: nanogirl@halcyon.com Alternate E-mail echoz@hotmail.com "Nanotechnology: solutions for the future." Get the Nanotechnology Industries newsletter at: http://www.homestead.com/nanonews/describe.html Personal home pages at: http://www.homestead.com/nanotechind/nothingatall.html - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: "Gina Miller" Subject: (associates) Nanogirl news Date: 08 Sep 1999 14:59:40 -0700 Nanogirl news~ Sept 8,99 *Mini-Motor Models Nature, Advances Miniaturization Technology. For the first time, researchers have designed from scratch a working, chemically powered, molecular motor. The device will advance atomic-level understanding of natural molecular motors that power muscle contraction, sperm swimming, and a myriad other biological processes. It is also an extraordinary example of miniaturization of technology. (NIH/National Institute of General Medical Science) http://www.nih.gov/nigms/news/releases/kelly.html *Entropy Systems New technology converts atmospheric heat to electricity. Produces zero emissions and uses no fossil or nuclear fuels. http://entropysystems.com/NewsRelease.htm *Scenario for high-temperature, cuprate superconductivity proposed. A University of Illinois theorist has proposed a "midinfrared" scenario that may help explain the mechanism behind high-temperature, cuprate (copper-containing) superconductors. http://www.eurekalert.org/releases/uiuc-sfh090799.html *Time Magazine articles: Racing To Map Our DNA. Competition from private labs has forced the Human Genome Project into a frantic rush to finish first. http://www.pathfinder.com/time/magazine/articles/0,3266,17688,00.html The Biotech Century: http://www.pathfinder.com/time/magazine/articles/0,3266,17687,00.html All for the Good, Why genetic engineering must soldier on (article) http://www.pathfinder.com/time/magazine/articles/0,3266,17679,00.html Was Einstein's Brain Built for Brilliance?Quite possibly, say Canadian researchers--and they may have pinpointed the source of his genius. http://www.pathfinder.com/time/magazine/articles/0,3266,27180,00.html *Snapshot of new drug marks a major advance by Memorial Sloan-Kettering researchers MSKCC scientists have achieved a major milestone in a line of research that has spanned a quarter-century: the first-ever molecular "snapshot" of a new drug interacting with its cellular target. http://www.mskcc.org/document/pr990908.htm *Hematopoietic Stem Cell Marker Finally Found. Hematopoietic stem cells, created by bone marrow, have two unique abilities: they can develop into any kind of blood cell, and they can self-renew by generating new daughter stem cells. Yet they are very rare, making up only 1 in 100,000 marrow cells, and they have been notoriously difficult to distinguish from the blood's other progenitor cells. http://unisci.com/stories/19993/0908993.htm *"The Planet That Hums" (New Scientist Planet Science) The earth we live on create's a hum (that we are unable to hear) at pitches that range between 2 and 7 millihertz. Musically speaking, that's about sixteen octaves below middle C. Speeded up and amplified so you could hear it, the result would be a Stockhausenesque cacophony. http://www.newscientist.co.uk/ns/19990911/theplanett.html *In September, readers of BBC News Online can vote for the greatest thinker of the millennium. Two experts, philosopher and writer Roger Scruton and lateral thinker Edward de Bono, have nominated their top 10 lists. But you may have other ideas. http://news.bbc.co.uk/hi/english/static/events/millennium/default.stm * Russia's vacant Mir space station went into hibernation early Wednesday after Mission Control shut down its main computer, a space official said. http://www.cnn.com/TECH/space/9909/08/russia.space.reut/index.html *John Maeda, artist and MIT professor, marries conceptual design and digital technology in new ways. (front page) http://www.foxnews.com/scitech/ *W. Richard Steven noted technology author and teacher died last Wednesday. Stevens was best known for his UNIX Network Programing series and and TCP/IP Illustrated book. The family has asked that in lieu of flowers, donations be made in Richard's name to Habitat for Humanity, 2950 E. 22nd Street, Tucson, AZ 85713. He is survived by his wife and three children. The cause of death was not reported. (See his Funeral Notice): http://www.bigdealclassifieds.com/classified/plsql/classlevel3_step?wClass=0 002&wPubdate= Friday&wRowstart=2&wLessOrMore= *CSpan site was cracked. See the original site at: http://www.c-span.org/ See the cracked site at: (brought to you by HN http://www.hackernews.com/archive/1999/cspan/mirror.html See the story at CNN http://www.cnn.com/TECH/computing/9909/05/cspan.hacked.ap/ *Plasma, Plasma, Everywhere - A NASA scientist has created a new model of the plasmasphere surrounding our world, building on the work of previous models. Earth's complicated plasma environment directly affects our life on Earth - from radio transmissions and power grids to satellite safety. http://science.nasa.gov/newhome/headlines/ast07sep99_1.htm *Scottish Hackers Replace Government A group of Scottish hackers called the "Hardcore Highland Haxxors," apparently isn't satisfied with the country's leadership, and yesterday took matters into its own hands. The group hacked into a government Web site. http://www.internetnews.com/rumblings/0,1145,81,00.html *(Wired) Scientists said on Tuesday they have pinpointed the first gene for dyslexia, a common learning disorder that affects spelling and writing. http://www.wired.com/news/news/technology/story/21600.html *Since the emergence of machine vision in the 1960s, debate has raged over whether a parallel or serial architecture is best. Researchers modeling visual processes in the brain observed parallelism in neural structures, but didn't know enough about how visual information was being represented to resolve the issue. Now University of Iowa researchers say they've solved this vision research question: Does the brain operate in parallel or serially? http://www.eetimes.com/story/technology/advanced/OEG19990908S0001 *Gadget Master Jacob Rabinow was the government's gadget guru for 50 years. At 88, he's still tinkering away. http://new.popsci.com/context/features/inventor/ *Group Seeks DNA Test On Ancient Human Skeleton. Hoping to prove that white people lived in North America 9,000 years ago, a small California religious group asked a U.S. federal court Tuesday to force the government to allow DNA testing of a prehistoric human skeleton found in Washington state in 1996. http://abcnews.go.com/wire/US/reuters19990907_3432.html *Gene tests set to allay couples' concern The Scotsman ROUTINE testing for would-be parents to give them the genetic all- clear is only a few years away, according to a leading expert in chromosomes. Dr Pat Ellis, the head of the South East Scotland Cytogenetics Service, which was officially opened yesterday, said couples would soon have the chance to be tested for chromosome abnormalities even before they considered trying to conceive. Dr Ellis emphasised that testing would not be compulsory and said that in the majority of cases it would be putting parents' minds at rest. If it turned out that parents were carrying abnormal chromosomes, then they could be counselled about the risks to any potential children they might have. "We expect progress to be rapid in the next few years. The human genome project {to map all known genes} is due to finish next year and we expect to be able to test for a wider range of disorders. Already we can screen for cystic fibrosis, spina bifida and Down's syndrome and we could test parents to see if there is a likelihood that they might pass the genes on to their children. "If we reach that stage, people would not be forced to be screened - that would be like 1984 and would be totally unacceptable. But in the majority of cases it would mean putting people's minds at rest." Pregnant women are already offered testing to find out whether there is a likelihood that the baby they are carrying will have a genetic illness. Parents of children who have disorders as a result of damaged chromosomes are also tested to find out if it is an inherited condition or if the cells became damaged in another way - a discovery which has implications for the whole family who can then decide whether they want to be tested for the faulty gene. The new centre, based at the Western General Hospital in Edinburgh, brings together experts in all aspects of genetics, as well as some of the most up-to-date equipment for testing for genetic disorders. Cytogenetics is the study of chromosomes, the collection of genes which determine the characteristics of a human being. The cytogenetic service will analyse genetic samples from patients with a range of disorders which could have an underlying genetic cause, including infertility and physical or mental handicap. The unit will carry out about 3,000 tests a year on blood, bone marrow and tissue samples, including 1,000 tests on antenatal patients to identify potential abnormalities in unborn babies. About 500 tests will involve patients with leukaemia, as examining chromosomes can show the exact type of illness, how far it has progressed and give pointers about the best course of treatment. The GBP 400,000 centre includes advanced technology such as the FISH (fluorescent in situ hybridisation) laboratory and image capture room which allows the scientists to see chromosomal abnormalities more precisely. Dr Ellis said: "This move is the culmination of many years of planning, matched by as many disappointments, as relocation proved unsuitable for many reasons. The opportunities which it affords for closer collaboration with our colleagues in clinical and molecular genetics, backed by modern, state-of-the-art equipment for studying chromosomes, can only improve the overall service offered to patients in this area with possible genetic disorders." The unit was opened by Barry Sealey, the chairman of the Lothian University Hospitals NHS Trust, who said: "There is a growing interest in conditions which are transmitted genetically and our unit plays a key role in identifying such conditions, particularly before and immediately after birth." *Britain may lose top GM technology The Independent - London A WORLD-BEATING British technology to make vaccines in genetically modified plants may be lost to the United States, because British investors are scared of the "GM" tag. Iain Cubitt, chief executive of Cambridge-based Axis Genetics, yesterday criticised a "failure of confidence" among City investors, who shied away from providing pounds 10m to fund the expansion of clinical trials of its products. Six weeks ago, an American university began human trials of a vaccine against hepatitis B, which kills one million people every year, made from GM potatoes produced by Axis Genetics. The company, which grew its crops in sealed greenhouses, was also working on GM plants including bananas to produce vaccines against diarrhoea and even cancer. If any of the products proves itself in trials it could be a massive moneyspinner. But when the funding fell short, the business last week laid off 25 of its 50 staff and has gone into administration, one step away from bankruptcy. With no obvious British buyer, a US biotechnology company - such as Monsanto - may be keen to acquire the technology. Dr Cubitt said: "I think it's a tremendous loss for us, as we have gone far enough already to show that there's a chance of succeeding." But he declined to say whether he had been approached by potential buyers. The company's problems make it one of the most visible casualties of the European backlash against genetically modified products, which was sparked in 1996 by American farmers' refusal to separate GM soya - which has no benefit to the consumer - from conventional strains. Opposition to the technology has snowballed in both Britain and continental Europe, forcing supermarkets and manufacturers to declare their foods GM-free. Last week, consumer pressure finally forced one of the biggest American soya processors to tell farmers to separate GM and conventional strains after harvest. Peter Melchett, executive director of Greenpeace UK, blamed the situation on pharmaceutical companies' decision to ally themselves with GM food techniques. "We told the Prime Minister earlier this year that if they didn't distinguish between medicines, and crops and food which involved releases to the environment, they would suffer in the backwash of the public's rejection of GM food." Dr Cubitt said: "Because we are genetically modifying plants, that can be confused in the public mind with all the other issues about GM food. Basically it's a lack of confidence among investors." *Gina "Nanogirl" Miller Nanotechnology Industries Web: http://www.nanoindustries.com E-mail: nanogirl@halcyon.com Alternate E-mail echoz@hotmail.com "Nanotechnology: solutions for the future." Get the Nanotechnology Industries newsletter http://www.homestead.com/nanonews/describe.html My personal webpages: http://www.homestead.com/nanotechind/nothingatall.html - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: Rich Thomson Subject: (associates) November technical conference Date: 15 Sep 1999 15:36:37 -0600 Hi fellow Senior Associates, How many of you are planning on attending the November technical conference and/or tutorial? -- Rich - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: Victor Brennen Subject: Re: (associates) November technical conference Date: 15 Sep 1999 18:14:01 -0400 (EDT) >Hi fellow Senior Associates, > >How many of you are planning on attending the November technical >conference and/or tutorial? I hope to attend the conference. I won't be attending the=20 tutorial. I've been a SA for 4 years and haven't attended any of the=20 conferences yet, so I figure it would be good for me to try and make it to at least one before my membership expires. =09- VAB --- V. Alex Brennen [vab@metanet.org] [http://www.metanet.org/people/vab/] F A R B E Y O N D D R I V E N "=BFC=F3mo habr=E1 de crecer este viento oculto, conforme ahora con soplar = en sierras y ca=F1adas, sin bajar a=FAn a los valles donde manda el dinero y gobierna la mentira? De la monta=F1a vendr=E1 este viento, nace ya bajo los =E1rboles y conspira por un nuevo mundo, tan nuevo que es apenas una intuici=F3n en el coraz=F3n colectivo que lo anima... " - Marcos - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: "Gina Miller" Subject: Re: (associates) November technical conference Date: 15 Sep 1999 15:33:03 -0700 I'll be attending. Gina "Nanogirl" Miller Nanotechnology Industries Web: http://www.nanoindustries.com E-mail: nanogirl@halcyon.com Alternate E-mail echoz@hotmail.com "Nanotechnology: solutions for the future." - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: Rich Thomson Subject: Re: (associates) November technical conference Date: 15 Sep 1999 19:24:32 -0600 Hi Victor, In article , Victor Brennen writes: > I hope to attend the conference. I won't be attending the=20 > tutorial. I have attended the conference 2 years in a row and the tutorial each time. (Each time they were different.) I am not a buckytube chemist or a molecular biologist or a hardcore materials researcher, so much of the technical portion of the conference is mostly far too specialized for me to be able to get much out of it. Ralph Merkle's and Josh Hall's presentations are always enjoyable for me. I got the most out of the tutorials, which were excellent. I like it when specialists in other fields give talks for specialists in other fields. So, you can assume they have a certain baseline technical knowledge and proficiency, but not necessarily in your specialization. You have enough common vocabulary and culture to get the key elements of your specialization communicated to other specialists not in your field. So far I haven't seen the CS community talk seriously about nanotech and its implications. Am I just not looking in the right place? "CS" is rapidly becoming balkanized into islands of specialization because the field is expanding too broadly and too quickly for anyone to keep an eye on the big picture without drowning in information overload. > I've been a SA for 4 years and haven't attended any of the=20 > conferences yet, so I figure it would be good for me to > try and make it to at least one before my membership expires. Heh heh... Foresight will be happy to have you as a senior associate in perpetuity, I bet... as long as you keep paying money they'll probably let you be "Grand Poobah" although the title might carry a premium ticket price ;-). I have paid my 5 year SA membership to Foresight and am now working on my 6th year, I think. I am at year 2 for IMM. What year did you first hear about nanotech? I heard about it through the sci.space newsgroup, of all places. I bought Engines around 1986/1987 when it first came out and was immediately smitten with the ideas ;-). -- Rich - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: Will Dye Subject: Re: (associates) November technical conference Date: 15 Sep 1999 20:51:28 -0500 On Wed, 15 Sep 1999 15:36:37 MDT, Rich Thomson writes: > How many of you are planning on attending the November technical > conference and/or tutorial? Much to my frustration, not me. I won't make it to *any* of the conferences this year, and next year looks bad, too. Sigh... Having "a life" certainly has some advantages, but it really cuts down on the amount of time I have for "stuff that matters". Like hacking on Crit, or finally getting to read the Xanadu source, or offering to help Eric by writing TCL scripts to make his existing modeling tools more MNT-friendly, or thinking about alternatives and/or improvements to the "Inheritance Day" scenario, or a number of other things I'd dearly love to do. I'm not saying that the people who get such things done never have lives, though. Many of them manage to handle both interesting work and a family life as well. Alas, I'm not one of them -- though I maintain hope that things will change as more of us can get regular jobs doing true MNT work. Of course, I've already managed to help out just a little bit, by becoming a Senior Associate. :-) --Will ___________________________________________________________________ William L. Dye \ "...it would seem that our Lord finds our Software Enginerd \ desires not too strong, but too weak... We willdye@dsndata.com \ are far too easily pleased." --C. S. Lewis - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: tmckendree@west.raytheon.com Subject: Re: (associates) November technical conference Date: 16 Sep 1999 10:12 -0700 (PDT) William L. Dye wrote: >> [Who's going to the Foresight Confernece?] > >Much to my frustration, not me. I won't make it to *any* of >the conferences this year, and next year looks bad, too. Sigh... Me either, and I understand your frustration. I'm working furiously on my dissertation, and not going to anything write now. I deliberately did *not* look at the description of the upcoming Senior Associates gathering. When my Sr. Associate letter came, however, I had a moment of weakness, and there's all these cool things I'm not going to see. Sigh, indeed. Tom McKendree tmckendree@west.raytheon.com - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: Mark Shepard Subject: Re: (associates) November technical conference Date: 16 Sep 1999 13:19:44 -0700 Rich- I'll be there -- conference only. BTW, does anyone know, are conference tapes available? Searching www.foresight.org revealed that tapes for the _first_ conference are (were?) available, but I didn't find anything about more recent conferences. I'd like to share some of cooler presentations from last year's conference with a few friends who are interested, but not enough to attend a conference. Seems like a good way to bring home to people the reality of nanotech. Mark Rich Thomson said: > How many of you are planning on attending the November technical > conference and/or tutorial? - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: "Peter C. McCluskey" Subject: Re: (associates) November technical conference Date: 16 Sep 1999 15:43:39 -0700 mns-associates@MetaThink.COM (Mark Shepard) writes: >Rich- > >I'll be there -- conference only. > >BTW, does anyone know, are conference tapes available? Searching >www.foresight.org revealed that tapes for the _first_ conference are (were?) >available, but I didn't find anything about more recent conferences. http://sound.photosynthesis.com has quite a few apparently available. Peter McCluskey | Critmail (http://crit.org/critmail.html): http://www.rahul.net/pcm | Accept nothing less to archive your mailing list - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: "Richard H. Smith, II, MS, CMPE" Subject: Re: (associates) November technical conference Date: 16 Sep 1999 19:10:23 -0400 Alas, I won't be there. I have to be on a panel on the future of healthcare at the annual meeting of the Medical Group Management Association. Of course, I will mention nanomedicine possibilities and Bob Frietas' book. Hope everyone is well. Dick Smith -- Richard H. Smith, II, MS, CMPE Alexandria, Virginia 202-966-9307 (w) 703-567-0404 (h) http://www.coatesandjarratt.com/smith.htm http://www.vt.edu:10021/arch/psk/papa6664/smith/rs.htm - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message. ------------------------------------------------------------------------------- From: "Gina Miller" Subject: (associates) Lecture/bio/nano Date: 24 Sep 1999 16:53:41 -0700 The Clear Lake Chapter of Sigma Xi, the Scientific Research Society, will host a lecture and dinner meeting on Thursday, September 30, 1999. The topic will be "Advances in Bioengineering, Biomaterials, and Nanotechnology Research". The Featured Speaker is Dr. Jennifer West, of Rice University. Time: Lecture at 6:00 pm; Dinner at 7:00 pm Place: China Square Restaurant 1111 NASA Road One (281-486-7722) The lecture is free. Those wishing to join us for dinner are individually responsible for their own dinner costs. See this url for more: http://sigmaxi73.db.uth.tmc.edu For additional information, contact: Lovely Fotedar, Ph.D.: (281) 483-7603 Bonnie Cooper, Ph.D.: (281) 336-4132 Richard Puzdrowski, Ph.D.: (281) 283-3750 Gina "Nanogirl" Miller Nanotechnology Industries Web: http://www.nanoindustries.com E-mail: nanogirl@halcyon.com "Nanotechnology: solutions for the future." Get your copy of the Nanotechnology Industries newsletter at: http://www.homestead.com/nanonews/describe.html Index to all my websites: http://www.homestead.com/nanotechind/nothingatall.html - To unsubscribe from associates, send an email to "majordomo@xmission.com" with "unsubscribe associates" in the body of the message. For information on digests or retrieving files and old messages send "help" to the same address. Do not use quotes in your message.